Schistosoma Haematobium Clinical Trial
Official title:
Randomized Double Blind Clinical Trial in Mali, Comparing the Effectiveness of Artesunate + Sulfamethoxypyrazine/Pyrimethamine Versus Praziquantel in the Treatment of S. Haematobium in Children
The purpose of this study is to evaluate the efficacy of praziquantel versus As+SMP (Co-Arinate FDC ®) in the treatment of Schistosoma haematobium in 6-15 year old Malian children. The nul-hypothesis in this study is that the combination of As+SMP is more effective than praziquantel in the treatment of S. haematobium infected children.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03893097 -
Evaluation of Artesunate-mefloquine as a Novel Alternative Treatment for Schistosomiasis in African Children
|
Phase 3 | |
Not yet recruiting |
NCT05941884 -
Possible Diagnostic Protein Markers in Schistosoma Related Bladder Diseases.
|
||
Withdrawn |
NCT02810613 -
Leiden University Medical Center Mini Donor Bank
|
N/A | |
Completed |
NCT00870649 -
Efficacy of Bilhvax in Association With Praziquantel for Prevention of Clinical Recurrences of Schistosoma Haematobium
|
Phase 3 | |
Completed |
NCT00713999 -
Urogenital Schistosomiasis and Sexually Transmitted Infections in Madagascar
|
N/A | |
Completed |
NCT01163877 -
Iron Absorption and Utilization in Adolescents Infected With Malaria Parasites, Hookworms or Schistosoma
|
N/A |